Realta Investment Advisors’s CorMedix CRMD Stock Holding History

Realta Investment Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-770	Closed	-$7K	–	1630
2019 Q2	$7K	Buy	+770	New	+$6.04K	﹤0.01%	1242

Other funds holding CRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Spinnaker Capital Boston, Massachusetts $1.08M AUM 45.28% 1-Year Est. Return

Realta Investment Advisors's CRMD Position: Q3 2019 in Review

Realta Investment Advisors sold out of CorMedix (CRMD) in Q3 2019, closing a stake of 770 shares — an estimated $7K sold.

Realta Investment Advisors first reported a position in CRMD in Q2 2019 and held it in 1 quarter. The position peaked at $7K in Q2 2019. 56 funds tracked by Wall St. Rank hold CRMD as of Q3 2019.

Realta Investment Advisors reported no remaining CorMedix position as of Q3 2019 after selling out during the quarter.
Realta Investment Advisors sold 770 CorMedix shares in Q3 2019, an estimated $7K.
Realta Investment Advisors first reported a position in CorMedix in Q2 2019 and held it in 1 quarter.
Realta Investment Advisors's CorMedix position peaked at $7K in Q2 2019.
56 funds tracked by Wall St. Rank held CorMedix as of Q3 2019.

Based on Realta Investment Advisors's 13F filing for Q3 2019, filed 18 Oct 2019.